No Data
Beijing Hotgen Biotech Co., Ltd (688068.SH) and its subsidiaries recently obtained 18 qualifications.
Beijing Hotgen Biotech Co., Ltd (688068.SH) issued an announcement that the company and its subsidiaries have recently obtained domestic medical instruments registration certificates.
Hejing Biotech: Beijing Hejing Biotechnology Co., Ltd. Report for the Third Quarter of 2024
Beijing Hejing Biotechnology Co., Ltd. Report for the Third Quarter of 2024
beijing hotgen biotech co.,ltd (688068.SH) released its performance for the first three quarters, with a net loss of 40.6386 million yuan.
Beijing Hotgen Biotech Co.,Ltd. (688068.SH) released the third quarter report for 2024, with revenue for the first three quarters of the company reaching ...
beijing hotgen biotech co.,ltd (688068.SH): net loss of 40.6386 million yuan in the first three quarters.
On October 30, 格隆汇 released an announcement, beijing hotgen biotech co.,ltd (688068.SH) achieved revenue of 0.386 billion yuan in the first three quarters of 2024, a decrease of 5.10% year-on-year; net income attributable to shareholders of the listed company was -40.6386 million yuan, with a basic earnings per share of -0.44 yuan.
beijing hotgen biotech co.,ltd (688068.SH) recently obtained 6 overseas qualifications certifications.
beijing hotgen biotech co.,ltd (688068.SH) announced that the company has recently obtained 6 overseas qualifications. The acquisition of the above qualifications...
No Data
No Data